1. Molecular pathogenesis in Diamond–Blackfan anemia

   • Etsuro Ito
   • Yuki Konno
   • Kiminori Terui

   Progress in Hematology 30 September 2010 Pages: 413 - 418

   

2. Recent progress in dyskeratosis congenita

   • Nobuhiro Nishio
   • Seiji Kojima

   Progress in Hematology 01 October 2010 Pages: 419 - 424

   

3. Hereditary sideroblastic anemia: pathophysiology and gene mutations

   • Hideo Harigae
   • Kazumichi Furuyama

   Progress in Hematology 17 September 2010 Pages: 425 - 431

   

4. Congenital dyserythropoietic anemia

   • Takahiro Kamiya
   • Atsushi Manabe

   Progress in Hematology 07 September 2010 Pages: 432 - 438

   

5. Loss of promoter methylation contributes to the expression of functionally impaired PRDM1β isoform in diffuse large B-cell lymphoma

   • Yi-Wen Zhang
   • Hong-Qiang Xie
   • Wei-Li Zhao

   Rapid Communication 22 September 2010 Pages: 439 - 444

   

6. Molecular basis and hematological features of hemoglobin variants in Southern Thailand

   • Vannarat Saechan
   • Chawadee Nopparatana
   • Suthat Fucharoen

   Original Article 14 September 2010 Pages: 445 - 450

7. Overexpression of PAX5 induces apoptosis in multiple myeloma cells

   • Maryse Proulx
   • Marie-Pierre Cayer
   • Daniel Jung

   Original Article 30 September 2010 Pages: 451 - 462

   

8. A retrospective analysis of obstetric patients with idiopathic thrombocytopenic purpura: a single center study

   • Atsuko Fujita
   • Rika Sakai
   • Shin Fujisawa

   Original Article 30 September 2010 Pages: 463 - 467

   

9. Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism

   • Mana Mitsuguro
   • Toshiyuki Sakata
   • Toshiyuki Miyata

   Original Article 23 September 2010 Pages: 468 - 473

   

10. Treatment of central nervous system lymphoma in rats with intraventricular rituximab and serum

    • Yasuyuki Miyake
    • Yasushi Okoshi
    • Shigeru Chiba

    Original Article 07 September 2010 Pages: 474 - 480

    

11. Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia

    • Misato Kikuchi
    • Junji Tanaka
    • Masahiro Imamura

    Original Article 10 September 2010 Pages: 481 - 489

    

12. Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

    • Itsuro Jinnai
    • Tohru Sakura
    • Ryuzo Ohno

    Original Article 10 September 2010 Pages: 490 - 502

    

13. A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma

    • Yasushi Takamatsu
    • Kazutaka Sunami
    • The Kyushu Hematology Organization for Treatment Study Group (K-HOT)

    Original Article 08 September 2010 Pages: 503 - 509

14. Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study

    • Sung Yong Oh
    • Won Seog Kim
    • Hyo-Jin Kim

    Original Article 14 September 2010 Pages: 510 - 517

    

15. Bortezomib and dexamethasone for Japanese patients with relapsed and refractory multiple myeloma: a single center experience

    • Natsue Igarashi
    • Takaaki Chou
    • Takuro Ishiguro

    Original Article 02 October 2010 Pages: 518 - 523

    

16. Thiamine-responsive megaloblastic anemia syndrome

    • Ali Bay
    • Mehmet Keskin
    • Fatma Gumruk

    Case Report 11 September 2010 Pages: 524 - 526

    

17. Transient abnormal myelopoiesis in a cytogenetically normal neonate

    • Kentaro Yanase
    • Keisuke Kato
    • Masahiro Tsuchida

    Case Report 23 September 2010 Pages: 527 - 530

    

18. A case of aggressive myeloma recognized shortly after the remission following high-dose chemotherapy with autologous peripheral blood stem cell transplantation

    • Kaname Ueda
    • Katsuhiro Miura
    • Jin Takeuchi

    Case Report 20 August 2010 Pages: 531 - 534

    

19. Bullous exudative retinal detachment due to infiltration of leukemic cells in a child with acute lymphoblastic leukemia

    • Kenichi Yoshida
    • Daisuke Hasegawa
    • Atsushi Manabe

    Case Report 14 September 2010 Pages: 535 - 537

    

20. A case report of acute lymphoblastic leukemia complicated by lactic acidosis

    • Hong Chang
    • Xiao Shuai
    • Ting Liu

    Case Report 30 September 2010 Pages: 538 - 541

    

21. Dasatinib followed by second allogeneic hematopoietic stem cell transplantation for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia after the first transplantation

    • Yoko Ishida
    • Kiriko Terasako
    • Yoshinobu Kanda

    Case Report 08 September 2010 Pages: 542 - 546

    

22. Hemophagocytic lymphohistiocytosis associated with myelodysplastic syndromes

    • Takahiro Tsuji
    • Hiroshi Yamasaki
    • Hiroyuki Tsuda

    Letter to the Editor 07 September 2010 Pages: 547 - 549

    

23. CD30-positive anaplastic variant diffuse large B cell lymphoma: a rare case presented with cutaneous involvement

    • Hiroki Asano
    • Yoichi Imai
    • Mineo Kurokawa

    Letter to the Editor 14 September 2010 Pages: 550 - 552

    

24. Giant granulocytic sarcoma of the vagina concurrent with acute myeloid leukemia with t(8;21)(q22;q22) translocation

    • Jun Imagawa
    • Yuka Harada
    • Hironori Harada

    Letter to the Editor 10 September 2010 Pages: 553 - 555

    

25. Hemorrhagic colonic ulcers caused by dasatinib for chronic myelogenous leukemia

    • Yukako Ono
    • Takehiko Mori
    • Shinichiro Okamoto

    Letter to the Editor 08 September 2010 Pages: 556 - 558

    

26. Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate

    • Naoto Takahashi
    • Yoshihiro Kameoka
    • Kenichi Sawada

    Letter to the Editor 14 September 2010 Pages: 559 - 561